I think he is one of those regulars that gets free drinks at the Joseph Moscato "fishy" restaurant. I guess he/she flip flops depending on the number of drinks they have.
How come the regulars at the "fishy" restaurant did not know about the state of affairs in this quarterly statement? Interesting.
It looks like they will need to burn through the rest of the 730 million in order to keep their salaries going. If shareholders do not vote to increase the amount of shares outstanding they it will be game over. What remedies do we shareholders have now? Based on the fact that they did not do the roll out of Antigen Express as promised 3 years ago and forced shareholders to vote for a roll back in order to get this done should be enough to get rid of this management.
I don't know about being awarded through a law suit or class action suit but I don't think Fletcher or this Board should be voted in based solely on the fact that they promised a roll out of Antigen Express 3 years ago, made shareholders vote on a roll back so that they could make this happen and then do absolutely nothing. On top of it all they don't even mention roll out anymore.
He is collecting a salary while he laughs at shareholders every time he does his Circle Jerk routine to get enough money in to keep his salaries going on and on and on.
They are not able to do any real funding. Remember that $10 million private placement from 3 years ago. Never happened. Under this management it never will. After 3 years they would know that they are not competent. So by now it is obvious that their only agenda is to keep on collecting salaries. The circle jerk will continue for another year so that they can keep on collecting salaries and NOTHING else. If this were not the case they would not even bother with a Proxy vote. They would step aside or close doors.
Can you get a few people together to buy enough shares to take control and replace this incompetent management? Then we long term shareholders would have some hope.
We need a partner for AE37. Dendreon has the market for the prostate cancer vaccine and they still have no pharma partner. Fletcher time to redeem yourself and show us that you are competent as a CEO. When pigs fly?
Not only are they incompetent I don't think they actually want to achieve anything. Except collecting salaries of course.
Looks like they have been dreamers for a long time. Remember when Fletcher said that the roll out of Antigen Express was imminent? That was 3 years ago. Remember when he said a $10 million private placement was imminent? That was 3 years ago. Remember when he tried to make us believe that the BS Amarantus deal was a licensing deal where Generex had to actually raise the money. That was 3 years ago. Remember Fletcher said he was bringing stability, transparency and increased shareholder value? That was 3 years ago. Today we have a 3 cent stock, no roll out, no partners and complete mystery about Oral-lyn in India.
Nah. I think Fletcher is the worst. Has never been able to attract any other investors except for the debenture holders. Remember the promise of the $10 million financing about 3 years ago? Nothing came of it. Instead he sold all assets to keep his salary going and once in a while goes back to the same old debenture holders to keep his salary train going. Have you ever seen a dent made to the company's debt? Nope. That is because the money goes towards his salary. So we are to believe that these products will ever reach the market under Fletcher? Fair question.
So the waiting game for a whole lot of nothing continues. First we were told to wait until the end of December for news from India. Nothing. Then we were supposed to hear about AE37 data at the end of January. Nothing. Now they say June for AE37. And as far as India goes we will probably hear nothing ever again like that BS Amarantus deal.
If you check the websites where they publish results of trials you will find that a LOT of NEGATIVE studies were published. Just because results are not optimal does not mean they never get published. Check it out.
I know it is a lengthy process. But if there was an interested party that came out of the meetings at JP Morgan they would not have to put out this type of announcement. There is confidentiality between two parties. Generex can share directly to a party who has shown some serious interest. This PR reads like no one has shown great interest and they still need to look for a partner or still need to do a lot of convincing. In the meantime these types of PRs can allow Fletcher to sell the rest of the 760 million shares in Treasury. Good to the last drop.
Back in January Fletcher said that they were going to give potential partners an update at the JP Morgan conference. I guess they, if they did indeed meet with anyone, did not get excited about that update in January. Now we wait until June. More time to sell the rest of the 760 million shares to keep the salaries going.